Get In Touch With Us
Medexus Pharmaceuticals Inc. endeavors to share all the information that our investors require in order to make informed investment decisions. For questions regarding our business operations, partnerships, our product pipeline/portfolio, or for general inquiries, please reach out us using the form provided.
Medexus Pharmaceuticals, Inc.
10 King Street East, Suite 600,
Toronto, Ontario,
Canada
M5C 1C3
Ken d’Entremont
Chief Executive Officer and Director
ken.dentremont@medexus.com
905-676-0800
Marcel Konrad
Chief Financial Officer
marcel.konrad@medexus.com
312-548-3139
Business Development or Partnering Inquiries
Ken d’Entremont
Business Development and Strategy
ken.dentremont@medexus.com
905-676-0800
Investor Relations (Canada)
Victoria Rutherford
Adelaide Capital
Tel: 480-625-5772
E-mail: victoria@adcap.ca
Direct Financial Strategies and Communication Inc.
Frank Candido
frank.candido@medexus.com
514-969-5530
USA: For adverse events, medical inquiries, and product-related concerns, please call 1-855-336-3322.
Canada: For adverse events, medical inquiries, and product-related concerns, please call 1-877-633-3987 or by written at MedexusPV@innomar-strategies.com.